Mandana Khalili, MD
Professor
Medicine
School of Medicine

Chief of Clinical Hepatology, San Francisco General Hospital Director, Clinical and Translational Research in Hepatology, San Francisco General Hospital Director, Investigator Development Unit, UCSF Research Coordinating Center to Reduce Disparities in Multiple Chronic Diseases (Health Equity Action Network) Co-Director, UCSF Mentor Training Program Co-Director, UCSF T32 Hepatology Training Program Editorial board member, Hepatology Journal

RESEARCH PROGRAM: Mandana Khalili is a Professor of Medicine in the Department of Medicine and Chief of Clinical Hepatology at Zuckerberg San Francisco General Hospital (ZSFG). She also serves as the Director of Clinical and Translational Research in Hepatology at ZSFG. Her research focuses on assessing and addressing health disparities related to viral hepatitis, nonalcoholic fatty liver disease, alcohol-associated liver disease, cirrhosis, and hepatocellular carcinoma including natural history, pathogenesis, metabolic complications, healthcare access and novel treatments. She has a longstanding track record of extramural funding in these areas and has served as PI or co-PI of several NIH-sponsored national and international networks. She currently serves as a PI for the NIDDK-sponsored Liver Cirrhosis Network and also Hepatitis B Research Network assessing the natural history and optimal management of patients with hepatitis B and cirrhosis. Her group previously evaluated mechanisms of insulin resistance and secretion in Latinos with and without hepatitis C infection and is now examining how alcohol affects insulin action and adipose tissue insulin resistance among this at high-risk populations. In collaboration with two VA hospitals, she is evaluating the impact of COVID pandemic and transitions in care delivery on telemedicine satisfaction, quality of life, cirrhosis management, liver cancer screening and substance use among vulnerable populations in order to implement measures and policies to provide equitable liver care. Her group is also evaluating alcohol treatment in patients with liver disease using a novel stepped care motivational interviewing and addiction medicine treatment in the hepatology setting. Additional studies include examining patient and provider knowledge, attitudes and barriers to viral hepatitis and fatty liver disease management and implementing novel patient-centered as well as provider interventions such as education through mobile app to enhance patient care and address barriers to care. Her group’s recent efforts in developing an integrated model of shelter-based hepatitis C screening and treatment within large homeless shelters in San Francisco and Minnesota has been successful in scaling up hepatitis C management in persons who inject drugs and homeless residents. She is a member of the Liver Cancer San Francisco Cancer Initiative (SF-CAN), which in partnership with the City and County of San Francisco and other health and community partners, is using interventional strategies to reduce cancer in the city. Dr. Khalili is passionate about mentoring trainees and junior faculty and she has mentored numerous trainee and faculty at all career stages. She is a recipient of a NIH-sponsored K24 award in mentoring junior investigators in liver disease and the co-Director (co-PI) of the T32 Training in Hepatology. She has campus wide leadership roles in mentoring as the Director of UCSF Mentor Training Program. She also currently serves as the Director of Investigator Development Unit of the Research Coordinating Center to Reduce Disparities in Multiple Chronic Diseases sponsored by NIMHD. Her diverse research program including translational research, natural history and epidemiology, community/participatory research, health services/disparity, and clinical trials provides the infrastructure for supporting junior investigators and in transitioning them to independence.

WEBSITES https://health-equity-action.org/ http://ctsi.ucsf.edu/about-us/team/programs/career-development-cd http://accelerate.ucsf.edu/training/mdp-people http://livercenter.ucsf.edu/members/mkhalili.html http://ctsi.ucsf.edu/news/about-ctsi/driving-excellence-mentoring-ucsf

• Telehepatology Use and Satisfaction among Vulnerable Cirrhosis Patients Across Three Healthcare Systems in the Coronavirus Disease Pandemic Era
  Gastro Hep Advances 2023 Athavale, Priyanka Wong, Robert J. Satre, Derek D. Monto, Alexander Cheung, Ramsey Chen, Jennifer Y. Batki, Steven L. Ostacher, Michael J. Snyder, Hannah R. Widiarto, Brigita D. Oh, Seo Yoon Liao, Meimei Viviani, Adele M. L. Khalili, Mandana
• Fatty Liver Education Promotes Physical Activity in Vulnerable Groups, Including Those with Unhealthy Alcohol Use
  Gastro Hep Advances 2023 Shyam Patel, Rebecca G. Kim, Amy M. Shui, Catherine Magee, Maggie Lu, Jennifer Chen, Michele Tana, Chiung-Yu Huang, Mandana Khalili
• Symptoms of Liver Disease During Tenofovir Therapy With or Without Peginterferon: Results from the Hepatitis B Research Network Immune Active Trial.
  Digestive diseases and sciences 2023 Evon DM, Lin HS, Khalili M, Wahed AS, Yim C, Fontana RJ, Hoofnagle JH, Hepatitis B Research Network (HBRN)
• Novel autoantibody targets identified in patients with autoimmune hepatitis (AIH) by PhIP-Seq reveals pathogenic insights.
  medRxiv : the preprint server for health sciences 2023 Klepper A, Kung A, Vazquez SE, Mitchell A, Mann S, Zorn K, Avila-Vargas I, Kari S, Tekeste M, Castro J, Lee B, Duarte M, Khalili M, Yang M, Wolters P, Price J, Perito E, Feng S, Maher JJ, Lai J, …
• Cross-sectional study on stigma and motivation to adhere to lifestyle modification among vulnerable populations with fatty liver disease.
  Obesity science & practice 2023 Medina SP, Kim RG, Magee C, Stapper N, Khalili M
• Human immunodeficiency virus coinfection differentially impacts hepatitis B virus viral markers based on hepatitis Be antigen status in patients with suppressed viremia.
  Journal of viral hepatitis 2023 Lisker-Melman M, King WC, Ghany MG, Chung RT, Hinerman AS, Cloherty GA, Khalili M, Jain MK, Sulkowski M, Sterling RK
• Use of HBV RNA and to predict change in serological status and disease activity in CHB.
  Hepatology (Baltimore, Md.) 2023 Ghany MG, King WC, Hinerman AS, Lok AS, Lisker-Melman M, Chung RT, Terrault N, Janssen HLA, Khalili M, Lee WM, Lau DTY, Cloherty GA, Sterling RK
• Immunostaining for hepatitis B viral antigens in liver: Association with clinical, biochemical, and virologic features of disease.
  Journal of gastroenterology and hepatology 2023 Kleiner DE, Lisker-Melman M, Wahed AS, Bhan AK, Nalesnik MA, Choi EK, Leonard KK, Ghany MG, Chung RT, Di Bisceglie AM, Hepatitis B Research Network
• Racial Disparities in Treatment Initiation and Outcomes of Chronic Hepatitis B Virus Infection in North America.
  JAMA network open 2023 Khalili M, Leonard KR, Ghany MG, Hassan M, Roberts LR, Sterling RK, Belle SH, Lok AS, Hepatitis B Research Network
• Withdrawal of Long-Term Nucleotide Analog Therapy in Chronic Hepatitis B: Outcomes From the Withdrawal Phase of the HBRN Immune Active Treatment Trial.
  The American journal of gastroenterology 2023 Feld JJ, Wahed AS, Fried M, Ghany MG, Di Bisceglie AM, Perrillo RP, Khalili M, Yang X, Belle SH, Janssen HLA, Terrault N, Lok AS, Hepatitis B Research Network (HBRN)
• Efficacy of a Primary Care-Based Mobile Application to Increase Hepatitis C Screening Among Asian Americans: A Secondary Analysis of a Randomized Clinical Trial.
  Open forum infectious diseases 2023 Khalili M, Kim NJ, Tsoh JY, Walsh JME, Elizabeth Goldman L, Park H, Lau I, Wong C, Gildengorin G, Nguyen TT
• Randomized Trial of Tenofovir With or Without Peginterferon Alfa Followed by Protocolized Treatment Withdrawal in Adults With Chronic Hepatitis B.
  The American journal of gastroenterology 2022 Terrault NA, Lok AS, Wahed AS, Ghany MG, Perrillo RP, Fried MW, Wong DK, Khalili M, Lau DTY, Sterling RK, Di Bisceglie AM, Lisker-Melman M, Cooper SL, Chung RT, Patel K, Roberts LR, Belle SH, Janssen …
• Inflammatory bowel disease type influences development of elevated liver enzymes.
  JGH open : an open access journal of gastroenterology and hepatology 2022 Cheng YW, McLean R, Sewell JL, Huang CY, Khalili M
• Noninvasive Fibrosis Screening in Fatty Liver Disease Among Vulnerable Populations: Impact of Diabetes and Obesity on FIB-4 Score Accuracy.
  Diabetes care 2022 Kim RG, Deng J, Reaso JN, Grenert JP, Khalili M
• Undiagnosed abnormal alanine transaminase levels in vulnerable populations: Impact of sex, race/ethnicity, and body mass.
  Obesity science & practice 2022 Kim RG, Khalili M
• Racial/ethnic differences in fibrosis prevalence and progression in biopsy-proven steatosis: A focus on the Asian American population.
  Hepatology communications 2022 Kim RG, Chu JN, Vittinghoff E, Deng J, Reaso JN, Grenert JP, Khalili M
• HBV transcription and translation persist despite viral suppression in HBV-HIV co-infected patients on antiretroviral therapy.
  Hepatology (Baltimore, Md.) 2022 Lisker-Melman M, Wahed AS, Ghany MG, Chung RT, King WC, Kleiner DE, Bhan AK, Khalili M, Jain MK, Sulkowski M, Wong DK, Cloherty G, Sterling RK
• Characteristics of Older Patients With Immunotolerant Chronic Hepatitis B Virus Infection.
  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2022 Feld JJ, King WC, Ghany MG, Chang KM, Terrault N, Perrillo RP, Khalili M, Hinerman AS, Janssen H, Lok AS, Hepatitis B Research Network (HBRN)
• Hepatitis B RNA and Core-Related Antigen Provide Value Beyond DNA in Evaluating e But Not Surface Antigen Clearance.
  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2022 King WC, Sterling RK, Hinerman AS, Lok ASF, Cloherty GA, Ghany MG, HBRN HBV NOVELASSAYS GROUP
• Evolution of Fatty Liver Disease and Relationship With Lipoproteins and Clinical Outcomes in Hepatitis B/Human Immunodeficiency Virus Coinfection.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2022 Khalili M, King WC, Kleiner DE, Chung RT, Bhan AK, Ghany MG, Sulkowski MS, Lisker-Melman M, Jain MK, Janssen HLA, Hinerman AS, Sanyal AJ, Sterling RK
• A prospective cohort study of renal function and bone turnover in adults with hepatitis B virus (HBV)-HIV co-infection with high prevalence of tenofovir-based antiretroviral therapy use.
  HIV medicine 2022 Gizaw A, King WC, Hinerman AS, Chung RT, Lisker-Melman M, Ghany MG, Khalili M, Jain MK, Graham J, Swift-Scanlan T, Kleiner DE, Sulkowski M, Wong DK, Sterling RK, HIV-HBV Cohort Study of the Hepatitis …
• Coverage, inequity and predictors of hepatitis B birth vaccination in Myanmar from 2011-2016: results from a national survey.
  BMC health services research 2022 Anderson ACT, Richards A, Delucchi K, Khalili M
• Gaps in Hepatitis A and Hepatitis B Vaccination Among Hepatitis C Antibody-Positive Individuals Experiencing Homelessness.
  Open forum infectious diseases 2022 Partida D, Powell J, Gonzalez D, Khalili M
• Reply to Li, Henry, and Nguyen.
  The American journal of gastroenterology 2022 Khalili M, Kleiner DE, King WC, Sterling RK, Ghany MG, Chung RT, Bhan AK, Rosenthal P, Lisker-Melman M, Ramachandran R, Lok AS
• Changes in serum hepatitis B surface and e antigen, interferon-inducible protein 10, and aminotransferase levels during combination therapy of immune-tolerant chronic hepatitis B.
  Hepatology (Baltimore, Md.) 2022 Perrillo R, Lin HS, Schwarz KB, Rosenthal P, Lisker-Melman M, Chung RT, Prokunina-Olsson L, Cloherty G, Feld J, Hepatitis B Research Network (HBRN)
• Formal Hepatitis C Education Increases Willingness to Receive Therapy in an On-site Shelter-Based HCV Model of Care in Persons Experiencing Homelessness.
  Open forum infectious diseases 2022 Partida D, Powell J, Ricco M, Naugle J, Magee C, Zevin B, Masson CL, Konadu Fokuo J, Gonzalez D, Khalili M
• Erratum to: Adherence to Hepatitis C Therapy in a Shelter-Based Education and Treatment Model Among Persons Experiencing Homelessness.
  Open forum infectious diseases 2022 Powell J, Ricco M, Naugle J, Magee C, Hassan H, Masson C, Braimoh G, Zevin B, Khalili M
• Soluble Immune Checkpoints Are Dysregulated in COVID-19 and Heavy Alcohol Users With HIV Infection.
  Frontiers in immunology 2022 Li W, Syed F, Yu R, Yang J, Xia Y, Relich RF, Russell PM, Zhang S, Khalili M, Huang L, Kacena MA, Zheng X, Yu Q
• Long-term Follow-up of Hepatitis C Patients Who Achieved Sustained Virologic Response in the Pragmatic PRIORITIZE Study.
  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2022 Lok AS, Moon J, Sherman KE, Khalili M, Fishbein D, Reddy KR, PRIORITIZE Study Team
• Incidence and prediction of HBsAg seroclearance in a prospective multi-ethnic HBeAg-negative chronic hepatitis B cohort.
  Hepatology (Baltimore, Md.) 2022 Terrault NA, Wahed AS, Feld JJ, Cooper SL, Ghany MG, Lisker-Melman M, Perrillo R, Sterling RK, Khalili M, Chung RT, Rosenthal P, Fontana RJ, Sarowar A, Lau DTY, Wang J, Lok AS, Janssen HLA
• Hepatitis C Screening Among Medicaid Patients With Schizophrenia, 2002-2012.
  Schizophrenia bulletin open 2022 Thomas MD, Vittinghoff E, Crystal S, Walkup J, Olfson M, Khalili M, Dahiya P, Keenan W, Cournos F, Mangurian C
• Health Within Reach-a Patient-Centered Intervention to Increase Hepatitis B Screening Among Asian Americans: a Randomized Clinical Trial.
  Journal of general internal medicine 2022 Khalili M, Kim NJ, Tsoh JY, Walsh JME, Goldman LE, Gildengorin G, Wong C, Tran MT, Yu E, Sharp MT, LeTran VH, Nguyen VV, Nguyen TT
• A Prospective Cohort Study of Novel Markers of Hepatitis B Virus Replication in Human Immunodeficiency Virus Coinfection.
  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2021 Chung RT, King WC, Ghany MG, Lisker-Melman M, Hinerman AS, Khalili M, Sulkowski M, Jain MK, Choi EK, Nalesnik MA, Bhan AK, Cloherty G, Wong DK, Sterling RK, HBV-HIV Cohort Study of the Hepatitis B …
• Reply.
  Hepatology (Baltimore, Md.) 2021 Ghany MG, King WC, Lisker-Melman M, Lok ASF, Terrault N, Janssen HLA, Khalili M, Chung RT, Lee WM, Lau DTY, Cloherty GA, Sterling RK
• Fatty Liver and the Coronavirus Disease 2019 Pandemic: Health Behaviors, Social Factors, and Telemedicine Satisfaction in Vulnerable Populations.
  Hepatology communications 2021 Kim RG, Medina SP, Magee C, Khalili M
• Disentangling the impact of alcohol use and hepatitis C on insulin action in Latino individuals.
  Alcoholism, clinical and experimental research 2021 Kim RG, Kramer-Feldman J, Bacchetti P, Grimes B, Burchard E, Eng C, Hu D, Hellerstein M, Khalili M
• Fatty Liver Disease in a Prospective North American Cohort of Adults With Human Immunodeficiency Virus and Hepatitis B Virus Coinfection.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2021 Khalili M, King WC, Kleiner DE, Jain MK, Chung RT, Sulkowski M, Lisker-Melman M, Wong DK, Ghany M, Sanyal A, Sterling RK
• Shelter-Based Integrated Model Is Effective in Scaling Up Hepatitis C Testing and Treatment in Persons Experiencing Homelessness.
  Hepatology communications 2021 Khalili M, Powell J, Park HH, Bush D, Naugle J, Ricco M, Magee C, Braimoh G, Zevin B, Fokuo JK, Masson CL
• Adherence to Hepatitis C Therapy in a Shelter-Based Education and Treatment Model Among Persons Experiencing Homelessness.
  Open forum infectious diseases 2021 Powell J, Ricco M, Naugle J, Magee C, Hassan H, Masson C, Braimoh G, Zevin B, Khalili M
• Comparison of HBV RNA and Hepatitis B Core Related Antigen With Conventional HBV Markers Among Untreated Adults With Chronic Hepatitis B in North America.
  Hepatology (Baltimore, Md.) 2021 Ghany MG, King WC, Lisker-Melman M, Lok ASF, Terrault N, Janssen HLA, Khalili M, Chung RT, Lee WM, Lau DTY, Cloherty GA, Sterling RK
• A Pragmatic, Randomized Controlled Trial of Oral Antivirals for the Treatment of Chronic Hepatitis C: The PRIORITIZE Study.
  Hepatology (Baltimore, Md.) 2021 Sulkowski MS, Moon JS, Sherman KE, Morelli G, Darling JM, Muir AJ, Khalili M, Fishbein DA, Hinestrosa F, Shiffman ML, Di Bisceglie A, Rajender Reddy K, Pearlman B, Lok AS, Fried MW, Stewart PW, Peter …
• A Prospective Study Evaluating Changes in Histology, Clinical and Virologic Outcomes in HBV-HIV Co-infected Adults in North America.
  Hepatology (Baltimore, Md.) 2021 Sterling RK, King WC, Khalili M, Chung RT, Sulkowski M, Jain MK, Lisker-Melman M, Ghany MG, Wong DK, Hinerman AS, Bhan AK, Wahed AS, Kleiner DE, HBV-HIV Cohort Study of the Hepatitis B Research …
• Hepatitis B e antigen loss in adults and children with chronic hepatitis B living in North America: A prospective cohort study.
  Journal of viral hepatitis 2021 Lee WM, King WC, Janssen HLA, Ghany MG, Fontana RJ, Fried M, Sterling RK, Feld JJ, Wang J, Mogul DB, Cooper SL, Bisceglie AMD, Hepatitis B Research Network (HBRN)
• Hepatic Steatosis and Steatohepatitis in a Large North American Cohort of Adults With Chronic Hepatitis B.
  The American journal of gastroenterology 2021 Khalili M, Kleiner DE, King WC, Sterling RK, Ghany MG, Chung RT, Bhan AK, Rosenthal P, Lisker-Melman M, Ramachandran R, Lok AS, ; and the Hepatitis B Research Network (HBRN)
• Patient-reported experiences with direct acting antiviral therapy in an integrated model of hepatitis C care in homeless shelters.
  Journal of viral hepatitis 2021 Kim S, Powell J, Naugle J, Ricco M, Magee C, Masson C, Zevin B, Bush D, Khalili M
• Low Incidence of Adverse Outcomes in Adults With Chronic Hepatitis B Virus Infection in the Era of Antiviral Therapy.
  Hepatology (Baltimore, Md.) 2021 Lok AS, Perrillo R, Lalama CM, Fried MW, Belle SH, Ghany MG, Khalili M, Fontana RJ, Sterling RK, Terrault N, Feld JJ, Di Bisceglie AM, Lau DTY, Hassan M, Janssen HLA, Hepatitis B Research Network (…
• Liver disease symptoms are associated with higher risk of adverse clinical outcomes: A longitudinal study of North American adults with chronic Hepatitis B.
  GastroHep 2021 Evon DM, Lin HS, Fontana RJ, Khalili M, Yim C, Wahed AS, Hoofnagle JH
• Clinical significance of quantitative e antigen in a cohort of hepatitis B virus-infected children and adults in North America.
  Journal of viral hepatitis 2021 Cooper SL, King WC, Mogul DB, Ghany MG, Schwarz KB, Hepatitis B Research Network (HBRN)
• Precore and Basal Core Promoter Hepatitis B Virus (HBV) Variants Are Present From a Young Age and Differ Across HBV Genotypes.
  Hepatology (Baltimore, Md.) 2021 Lau DTY, Ganova-Raeva L, Wang J, Mogul D, Chung RT, Lisker-Melman M, Chang KM, Shaikh OS, Janssen HLA, Wahed AS, Lok AS, Hepatitis B Research Network
• Highly multiplexed 2-dimensional imaging mass cytometry analysis of HBV-infected liver.
  JCI insight 2021 Traum D, Wang YJ, Schwarz KB, Schug J, Wong DK, Janssen H, Terrault NA, Khalili M, Wahed AS, Murray KF, Rosenthal P, Ling SC, Rodriguez-Baez N, Sterling RK, Lau DT, Block TM, Feldman MD, Furth EE, Lee…
• Performance of Serum-Based Scores for Identification of Mild Hepatic Steatosis in HBV Mono-infected and HBV-HIV Co-infected Adults.
  Digestive diseases and sciences 2021 Sterling RK, King WC, Khalili M, Kleiner DE, Hinerman AS, Sulkowski M, Chung RT, Jain MK, Lisker-Melman MA, Wong DK, Ghany MG, HBV-HIV Cohort Study of the Hepatitis B Research Network
• Rural-Urban Geographical Disparities in Hepatocellular Carcinoma Incidence Among US Adults, 2004-2017.
  The American journal of gastroenterology 2021 Wong RJ, Saab S, Konyn P, Sundaram V, Khalili M
• Reply.
  Hepatology communications 2020 Powell J, Khalili M
• Provider Attitudes Toward Risk-Based Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis in the United States.
  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2020 Kim NJ, Rozenberg-Ben-Dror K, Jacob DA, Rich NE, Singal AG, Aby ES, Yang JD, Nguyen V, Pillai A, Fuchs M, Moon AM, Shroff H, Agarwal PD, Perumalswami P, Chandna S, Zhou K, Patel YA, Latt NL, Wong R, …
• A Patient-Centered Hepatitis B Virus (HBV) Educational Intervention Improves HBV Care Among Underserved Safety-Net Populations.
  Journal of clinical gastroenterology 2020 Wong RJ, Khalili M
• Global real-world evidence of sofosbuvir/velpatasvir as simple, effective HCV treatment: Analysis of 5552 patients from 12 cohorts.
  Liver international : official journal of the International Association for the Study of the Liver 2020 Mangia A, Milligan S, Khalili M, Fagiuoli S, Shafran SD, Carrat F, Ouzan D, Papatheodoridis G, Ramji A, Borgia SM, Wedemeyer H, Losappio R, Pérez-Hernandez F, Wick N, Brown RS, Lampertico P, Doucette …
• Clients' perceptions of barriers and facilitators to implementing hepatitis C virus care in homeless shelters.
  BMC infectious diseases 2020 Masson CL, Fokuo JK, Anderson A, Powell J, Zevin B, Bush D, Khalili M
• Maternal knowledge of the risk of vertical transmission and offspring acquisition of hepatitis B.
  Annals of hepatology 2020 Lisker-Melman M, Khalili M, Belle SH, Terrault NA, Lin HS, Smith CI, Chung RT, Tsai N, Bzowej NH, Tran TT, Schwarzenberg SJ, Hepatitis B Research Network (HBRN)
• Patient Knowledge, Beliefs and Barriers to Hepatitis B Care: Results of a Multicenter, Multiethnic Patient Survey.
  Digestive diseases and sciences 2020 Mukhtar NA, Evon DM, Yim C, Lok AS, Lisha N, Lisker-Melman M, Hassan M, Janssen HLA, Khalili M
• Recommendations for Implementing Hepatitis C Virus Care in Homeless Shelters: The Stakeholder Perspective.
  Hepatology communications 2020 Fokuo JK, Masson CL, Anderson A, Powell J, Bush D, Ricco M, Zevin B, Ayala C, Khalili M
• Alcohol, tobacco and coffee consumption and liver disease severity among individuals with Chronic Hepatitis B infection in North America.
  Annals of hepatology 2020 Brahmania M, Liu S, Wahed AS, Yim C, Hansen BE, Khalili M, Terrault NA, Lok AS, Ghany M, Wang J, Wong D, Janssen HLA, Hepatitis B Research Network
• Patient-reported outcomes in a large North American cohort living with chronic hepatitis B virus: a cross-sectional analysis.
  Alimentary pharmacology & therapeutics 2020 Evon DM, Lin HS, Khalili M, Fontana RJ, Yim C, Wahed AS, Fried MW, Hoofnagle JH, Hepatitis B Research Network (HBRN)
• Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial.
  Lancet (London, England) 2019 Younossi ZM, Ratziu V, Loomba R, Rinella M, Anstee QM, Goodman Z, Bedossa P, Geier A, Beckebaum S, Newsome PN, Sheridan D, Sheikh MY, Trotter J, Knapple W, Lawitz E, Abdelmalek MF, Kowdley KV, Montano…
• Phase Transition Is Infrequent Among North American Adults With e-Antigen-Negative Chronic Hepatitis B and Low-Level Viremia.
  The American journal of gastroenterology 2019 Zhou K, Wahed AS, Cooper S, Di Bisceglie AM, Fontana RJ, Ghany MG, Khalili M, Lok AS, Perrillo R, Lee WM, Lau DTY, Sterling R, Janssen HLA, Terrault NA
• Evaluating Noninvasive Markers to Identify Advanced Fibrosis by Liver Biopsy in HBV/HIV Co-infected Adults.
  Hepatology (Baltimore, Md.) 2019 Sterling RK, King WC, Wahed AS, Kleiner DE, Khalili M, Sulkowski M, Chung RT, Jain MK, Lisker-Melman M, Wong DK, Ghany MG, HIV-HBV Cohort Study of the Hepatitis B Research Network
• Total Alanine Aminotransferase (ALT) Flares in Pregnant North American Women With Chronic Hepatitis B Infection: Results From a Prospective Observational Study.
  The American journal of gastroenterology 2019 Bzowej NH, Tran TT, Li R, Belle SH, Smith CI, Khalili M, Chung R, Tsai N, Terrault N, Hepatitis B Research Network (HBRN)
• Hepatitis C Screening in an Underserved U.S. Cohort of Reproductive Age Women.
  Hepatology communications 2019 Kim NJ, Holguin D, Bush D, Khalili M
• Age, race and viral genotype are associated with the prevalence of hepatitis B e antigen in children and adults with chronic hepatitis B.
  Journal of viral hepatitis 2019 Di Bisceglie AM, King WC, Lisker-Melman M, Khalili M, Belle SH, Feld JJ, Ghany MG, Janssen HLA, Lau D, Lee WM, Ling SC, Cooper S, Rosenthal P, Schwarz KB, Sterling RK, Teckman JH, Terrault N, …
• Spectrum of Liver Disease in Hepatitis B Virus (HBV) Patients Co-infected with Human Immunodeficiency Virus (HIV): Results of the HBV-HIV Cohort Study.
  The American journal of gastroenterology 2019 Sterling RK, Wahed AS, King WC, Kleiner DE, Khalili M, Sulkowski M, Chung RT, Jain MK, Lisker-Melman M, Wong DK, Ghany MG, HIV-HBV Cohort Study of the Hepatitis B Research Network
• Distinct phenotype and function of circulating Vδ1+ and Vδ2+ γδT-cells in acute and chronic hepatitis B.
  PLoS pathogens 2019 Chang KM, Traum D, Park JJ, Ho S, Ojiro K, Wong DK, Wahed AS, Terrault NA, Khalili M, Sterling RK, Janssen HLA, Shuhart MC, Lau DT, Roberts LR, Johnson GS, Kaplan DE, Betts MR, Lee WM, Lok ASF, …
• Prevalence and Impact of Hepatitis E Virus Infection Among Persons With Chronic Hepatitis B Living in the US and Canada.
  Open forum infectious diseases 2019 McGivern DR, Lin HS, Wang J, Benzine T, Janssen HLA, Khalili M, Lisker-Melman M, Fontana RJ, Belle SH, Fried MW
• Entecavir and Peginterferon Alfa-2a in Adults With Hepatitis B e Antigen-Positive Immune-Tolerant Chronic Hepatitis B Virus Infection.
  Hepatology (Baltimore, Md.) 2019 Feld JJ, Terrault NA, Lin HS, Belle SH, Chung RT, Tsai N, Khalili M, Perrillo R, Cooper SL, Ghany MG, Janssen HLA, Lok AS, Hepatitis B Research Network
• Association Between Severe Serum Alanine Aminotransferase Flares and Hepatitis B e Antigen Seroconversion and HBV DNA Decrease in Untreated Patients With Chronic HBV Infection.
  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2019 Brahmania M, Lombardero M, Hansen BE, Terrault NA, Lok AS, Perrillo RP, Belle SH, Di Bisceglie AM, Feld JJ, Lee WM, Fried MW, Janssen HLA, Hepatitis B Research Network
• HBV Genotype-Specific Levels of Hepatitis B Surface Antigen Improve HBV Phenotype Definition.
  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2019 Brouwer WP, Zhao Q, Hansen BE, Lau D, Khalili M, Terrault NA, Di Bisceglie AM, Perrillo RP, Fried MW, Wong D, Feld JJ, Belle SH, Janssen HLA, Hepatitis B Research Network
• Underserved Does Not Mean Undeserved: Unfurling the HCV Care in the Safety Net.
  Digestive diseases and sciences 2018 Khalili M, Wong RJ
• Liver Disease Monitoring Practices After Hepatitis C Cure in the Underserved Population.
  Hepatology communications 2018 Kim NJ, Magee C, Cummings C, Park H, Khalili M
• Race and Hepatitis C Care Continuum in an Underserved Birth Cohort.
  Journal of general internal medicine 2018 Kim NJ, Locke CJ, Park H, Magee C, Bacchetti P, Khalili M
• Race/ethnicity is an independent risk factor for autoimmune hepatitis among the San Francisco underserved.
  Autoimmunity 2018 Lee B, Holt EW, Wong RJ, Sewell JL, Somsouk M, Khalili M, Maher JJ, Tana MM
• Direct Acting Antivirals Improve HCV Treatment Initiation and Adherence Among Underserved African Americans.
  Annals of hepatology 2018 Beck KR, Kim NJ, Khalili M
• Relationship Between Metabolic Syndrome, Alanine Aminotransferase Levels, and Liver Disease Severity in a Multiethnic North American Cohort With Chronic Hepatitis B.
  Diabetes care 2018 Khalili M, Shuhart MC, Lombardero M, Feld JJ, Kleiner DE, Chung RT, Terrault NA, Lisker-Melman M, Sanyal A, Lok AS, Hepatitis B Research Network (HBRN), Harvard Consortium
• Impact of Moderate Alcohol Discontinuation on Insulin Action and Secretion in Latinos With and Without Hepatitis C.
  Alcoholism, clinical and experimental research 2018 Uribe LA, Bacchetti P, Gelman N, Burchard E, Fitch M, Hellerstein M, Khalili M
• Hospitalizations for Autoimmune Hepatitis Disproportionately Affect Black and Latino Americans.
  The American journal of gastroenterology 2018 Wen JW, Kohn MA, Wong R, Somsouk M, Khalili M, Maher J, Tana MM
• Memory T Cell Proliferation before Hepatitis C Virus Therapy Predicts Antiviral Immune Responses and Treatment Success.
  Journal of immunology (Baltimore, Md. : 1950) 2017 Méndez-Lagares G, Lu D, Chen C, Terrault N, Segal MR, Khalili M, Monto A, Shen H, Manos MM, Lanier LL, Ryan JC, McCune JM, Hartigan-O'Connor DJ
• Provider, Patient, and Practice Factors Shape Hepatitis B Prevention and Management by Primary Care Providers.
  Journal of clinical gastroenterology 2017 Mukhtar NA, Kathpalia P, Hilton JF, Lau G, Yu A, Grumbach K, Nguyen TT, Chan D, Khalili M
• Prevalence of hepatitis B antiviral drug resistance variants in North American patients with chronic hepatitis B not receiving antiviral treatment.
  Journal of viral hepatitis 2017 Lok AS, Ganova-Raeva L, Cloonan Y, Punkova L, Lin HS, Lee WM, Ghany MG, Hepatitis B Research Network (HBRN)
• Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection.
  The New England journal of medicine 2017 Bourlière M, Gordon SC, Flamm SL, Cooper CL, Ramji A, Tong M, Ravendhran N, Vierling JM, Tran TT, Pianko S, Bansal MB, de Lédinghen V, Hyland RH, Stamm LM, Dvory-Sobol H, Svarovskaia E, Zhang J, Huang…
• Determination of hepatitis B phenotype using biochemical and serological markers.
  Journal of viral hepatitis 2016 Di Bisceglie AM, Lombardero M, Teckman J, Roberts L, Janssen HL, Belle SH, Hoofnagle JH, Hepatitis B Research Network (HBRN)
• Sofosbuvir-Containing Regimens for Chronic Hepatitis C Are Successful in the Safety-Net Population: A Real-World Experience.
  Digestive diseases and sciences 2016 Beck KR, Kim N, Khalili M
• Moderate Alcohol Use and Insulin Action in Chronic Hepatitis C Infection.
  Digestive diseases and sciences 2016 Burman BE, Bacchetti P, Khalili M
• Hepatitis C Screening Rate Among Underserved Adults With Serious Mental Illness Receiving Care in California Community Mental Health Centers.
  American journal of public health 2016 Trager E, Khalili M, Masson CL, Vittinghoff E, Creasman J, Mangurian C
• Fatigue in Patients with Chronic Hepatitis B Living in North America: Results from the Hepatitis B Research Network (HBRN).
  Digestive diseases and sciences 2016 Evon DM, Wahed AS, Johnson G, Khalili M, Lisker-Melman M, Fontana RJ, Sarkar S, Reeve BB, Hoofnagle JH
• Hepatitis B Virus--Specific and Global T-Cell Dysfunction in Chronic Hepatitis B.
  Gastroenterology 2015 Park JJ, Wong DK, Wahed AS, Lee WM, Feld JJ, Terrault N, Khalili M, Sterling RK, Kowdley KV, Bzowej N, Lau DT, Kim WR, Smith C, Carithers RL, Torrey KW, Keith JW, Levine DL, Traum D, Ho S, Valiga ME, …
• Impact of gender and menopausal status on metabolic parameters in chronic hepatitis C infection.
  Journal of viral hepatitis 2015 Gonzales CA, Bacchetti P, Khalili M
• Is there a relationship between hepatitis B surface antibody status and diabetes?
  Journal of diabetes 2015 Khalili M, Sanyal A
• Diabetes and prediabetes in patients with hepatitis B residing in North America.
  Hepatology (Baltimore, Md.) 2015 Khalili M, Lombardero M, Chung RT, Terrault NA, Ghany MG, Kim WR, Lau D, Lisker-Melman M, Sanyal A, Lok AS, HBRN
• Reasons for HCV non-treatment in underserved African Americans: implications for treatment with new therapeutics.
  Annals of hepatology 2015 Schaeffer S, Khalili M
• The birth and potential death of IL28B genotyping for hepatitis C therapy.
  Personalized medicine 2015 Wu AH, Khalili M
• Assessment of HBV preventive services in a medically underserved Asian and Pacific Islander population using provider and patient data.
  Journal of general internal medicine 2014 Mukhtar NA, Toy BC, Burman BE, Yu A, Chen AH, Berman P, Nguyen T, Chan D, Hammer H, McCulloch CE, Khalili M
• Liver inflammation is a risk factor for prediabetes in at-risk latinos with and without hepatitis C infection.
  Liver international : official journal of the International Association for the Study of the Liver 2014 Burman BE, Bacchetti P, Ayala CE, Gelman N, Melgar J, Khalili M
• Depression is not associated with peripheral insulin resistance in patients with chronic hepatitis C infection.
  Journal of viral hepatitis 2014 Shah SC, Kornak J, Khalili M
• Characteristics of adults in the hepatitis B research network in North America reflect their country of origin and hepatitis B virus genotype.
  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2014 Ghany MG, Perrillo R, Li R, Belle SH, Janssen HL, Terrault NA, Shuhart MC, Lau DT, Kim WR, Fried MW, Sterling RK, Di Bisceglie AM, Han SH, Ganova-Raeva LM, Chang KM, Lok AS, Hepatitis B Research …
• Education and counseling in the methadone treatment setting improves knowledge of viral hepatitis.
  Journal of substance abuse treatment 2013 Larios SE, Masson CL, Shopshire MS, Hettema J, Jordan AE, McKnight C, Young C, Khalili M, Seewald RM, Min A, Hengl N, Sorensen JL, Des Jarlais DC, Perlman DC
• Hepatitis B management in vulnerable populations: gaps in disease monitoring and opportunities for improved care.
  Digestive diseases and sciences 2013 Burman BE, Mukhtar NA, Toy BC, Nguyen TT, Chen AH, Yu A, Berman P, Hammer H, Chan D, McCulloch CE, Khalili M
• A randomized trial of a hepatitis care coordination model in methadone maintenance treatment.
  American journal of public health 2013 Masson CL, Delucchi KL, McKnight C, Hettema J, Khalili M, Min A, Jordan AE, Pepper N, Hall J, Hengl NS, Young C, Shopshire MS, Manuel JK, Coffin L, Hammer H, Shapiro B, Seewald RM, Bodenheimer HC, …
• Hepatocellular screening in hepatitis-B infected Asian Americans.
  Journal of viral hepatitis 2013 Khalili M, Stewart S
• Formal hepatitis C education enhances HCV care coordination, expedites HCV treatment and improves antiviral response.
  Liver international : official journal of the International Association for the Study of the Liver 2013 Lubega S, Agbim U, Surjadi M, Mahoney M, Khalili M
• Insulin sensitivity and variability in hepatitis C virus infection using direct measurement.
  Digestive diseases and sciences 2012 Mukhtar NA, Bacchetti P, Ayala CE, Melgar J, Christensen S, Maher JJ, Khalili M
• A mentor development program for clinical translational science faculty leads to sustained, improved confidence in mentoring skills.
  Clinical and translational science 2012 Feldman MD, Steinauer JE, Khalili M, Huang L, Kahn JS, Lee KA, Creasman J, Brown JS
• Impact of insulin resistance on HCV treatment response and impact of HCV treatment on insulin sensitivity using direct measurements of insulin action.
  Diabetes care 2012 Brandman D, Bacchetti P, Ayala CE, Maher JJ, Khalili M
• Hepatocellular carcinoma screening practices and impact on survival among hepatitis B-infected Asian Americans.
  Journal of viral hepatitis 2012 Sarkar M, Stewart S, Yu A, Chen MS, Nguyen TT, Khalili M
• Assessment of factors associated with pre-diabetes in HCV infection including direct and dynamic measurements of insulin action.
  Journal of viral hepatitis 2011 Mukhtar NA, Ayala C, Maher JJ, Khalili M
• Racial differences in hepatitis C treatment eligibility.
  Hepatology (Baltimore, Md.) 2011 Melia MT, Muir AJ, McCone J, Shiffman ML, King JW, Herrine SK, Galler GW, Bloomer JR, Nunes FA, Brown KA, Mullen KD, Ravendhran N, Ghalib RH, Boparai N, Jiang R, Noviello S, Brass CA, Albrecht JK, …
• Hepatitis B and hepatocellular carcinoma screening among Asian Americans: survey of safety net healthcare providers.
  Digestive diseases and sciences 2010 Khalili M, Guy J, Yu A, Li A, Diamond-Smith N, Stewart S, Chen M, Nguyen T
• Formal patient education improves patient knowledge of hepatitis C in vulnerable populations.
  Digestive diseases and sciences 2010 Surjadi M, Torruellas C, Ayala C, Yee HF, Khalili M
• Hepatitis C virus treatment-related anemia is associated with higher sustained virologic response rate.
  Gastroenterology 2010 Sulkowski MS, Shiffman ML, Afdhal NH, Reddy KR, McCone J, Lee WM, Herrine SK, Harrison SA, Poordad FF, Koury K, Deng W, Noviello S, Pedicone LD, Brass CA, Albrecht JK, McHutchison JG, IDEAL Study Team
• Comparison of surrogate and direct measurement of insulin resistance in chronic hepatitis C virus infection: impact of obesity and ethnicity.
  Hepatology (Baltimore, Md.) 2010 Lam KD, Bacchetti P, Abbasi F, Ayala CE, Loeb SM, Shah V, Wen MJ, Reaven GM, Maher JJ, Khalili M
• A glimpse of future hepatitis C virus treatment paradigms.
  Hepatology (Baltimore, Md.) 2010 Terrault N, Khalili M
• Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection.
  The New England journal of medicine 2009 McHutchison JG, Lawitz EJ, Shiffman ML, Muir AJ, Galler GW, McCone J, Nyberg LM, Lee WM, Ghalib RH, Schiff ER, Galati JS, Bacon BR, Davis MN, Mukhopadhyay P, Koury K, Noviello S, Pedicone LD, Brass CA…
• Long-term histological effects of preemptive antiviral therapy in liver transplant recipients with hepatitis C virus infection.
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2008 Kuo A, Tan V, Lan B, Khalili M, Feng S, Roberts JP, Terrault NA
• Coinfection with Hepatitis Viruses and HIV Update. In: Peiperl L, Volberding PA, eds. HIV InSite Knowledge Base [textbook on-line]
  Coinfection with Hepatitis Viruses and HIV Update. In: Peiperl L, Volberding PA, eds. HIV InSite Knowledge Base [textbook on-line] 2006 Khalili M
• Management of hepatitis C-infected liver transplant recipients at large North American centres: changes in recent years.
  Clinical transplantation 2006 Khalili M, Vardanian AJ, Hamerski CM, Wang R, Bacchetti P, Roberts JP, Terrault NA
• Pegylated interferon alpha-2a with or without ribavirin in HCV/HIV coinfection: partially blinded, randomized multicenter trial.
  Digestive diseases and sciences 2005 Khalili M, Bernstein D, Lentz E, Barylski C, Hoffman-Terry M
• Applicability, tolerability and efficacy of preemptive antiviral therapy in hepatitis C-infected patients undergoing liver transplantation.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2005 Shergill AK, Khalili M, Straley S, Bollinger K, Roberts JP, Ascher NA, Terrault NA
• Relative effects of insulin resistance and protease inhibitor treatment on lipid and lipoprotein metabolism in HIV-infected patients.
  HIV clinical trials 2004 Beatty G, Chu J, Kulkarni K, Lipshutz G, Khalili M, Abbasi F, Stansell J, Reaven GM
• Treatment of the hepatitis C virus in patients coinfected with HIV.
  Gastroenterology clinics of North America 2004 Khalili M, Proietti N
• Daily versus thrice-weekly interferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected persons: a multicenter randomized controlled trial.
  Journal of acquired immune deficiency syndromes (1999) 2004 Sulkowski MS, Felizarta F, Smith C, Slim J, Berggren R, Goodman R, Ball L, Khalili M, Dieterich DT, Hepatitis Resource Network Clinical Trials Group
• New onset diabetes mellitus after liver transplantation: the critical role of hepatitis C infection.
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2004 Khalili M, Lim JW, Bass N, Ascher NL, Roberts JP, Terrault NA
• Methods for quantifying insulin resistance in human immunodeficiency virus-positive patients.
  Metabolism: clinical and experimental 2003 Chu JW, Abbasi F, Beatty GW, Khalili M, Koch J, Rosen A, Schmidt JM, Stansell JD, Reaven GM
• Quantification of insulin-mediated glucose disposal in HIV-infected individuals: comparison of patients treated and untreated with protease inhibitors.
  Journal of acquired immune deficiency syndromes (1999) 2003 Beatty G, Khalili M, Abbasi F, Chu J, Reaven GM, Rosen A, Schmidt JM, Stansell J, Koch J
• Peiperl L, Volberding PA, eds. HIV InSite Knowledge Base [textbook on-line]
  Coinfection with Hepatitis Viruses and HIV Update 2003 Khalili M
• Hepatitis C in the setting of HIV co-infection.
  Microbes and infection 2002 Khalili M, Behm BW
• [Long-term follow-up of 700 trabeculectomies].
  Klinische Monatsblatter fur Augenheilkunde 2000 Khalili MA, Diestelhorst M, Krieglstein GK
• Interferon and ribavirin versus interferon and amantadine in interferon nonresponders with chronic hepatitis C.
  The American journal of gastroenterology 2000 Khalili M, Denham C, Perrillo R
• Interferon Therapy of Hepatitis B
  Clin Liver Dis 1999 Khalili M, Perrillo RP
• Trabeculectomy: a retrospective follow-up of 700 eyes.
  International ophthalmology 1998 Diestelhorst M, Khalili MA, Krieglstein GK
• Ionescu-Shiley valve failure. I: Experience with 125 standard-profile explants.
  The Annals of thoracic surgery 1992 Walley VM, Keon CA, Khalili M, Moher D, Campagna M, Keon WJ
• Ionescu-Shiley valve failure. II: Experience with 25 low-profile explants.
  The Annals of thoracic surgery 1992 Walley VM, Keon CA, Khalili M, Moher D, Campagna M, Keon WJ
• The University of Ottawa Heart Institute Cardiac Transplant Program: the first 100 transplants. A pathologic study of the explanted hearts.
  Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1992 Wolfsohn AL, Walley VM, Davies RA, Keon CA, Khalili M, Keon WJ